Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
An AI-generated site capture flags removed ductwork requiring rework on a commercial interior build-out, illustrating how OpenSpace and Disperse technology surfaces quality and progress issues from ...
NEW YORK--(BUSINESS WIRE)--Syntax Health, Inc., an enterprise SaaS-based solution for health plans and providers that accelerates alignment in value-based care (VBC), today announced the launch of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback